Tinosporide

Tinosporide is a clerodane-type diterpenoid lactone isolated primarily from Tinospora cordifolia, a plant used in Ayurvedic medicine. Its most studied mechanism involves inhibition of acetylcholinesterase (AChE), the enzyme responsible for breaking down the neurotransmitter acetylcholine, suggesting potential cognitive and neuroprotective applications.

Origin & History

Tinosporide is a clerodane-type furanoditerpenoid isolated from the stems of Tinospora cordifolia (Guduchi or Giloy), a climbing shrub native to India used in Ayurvedic medicine. It is extracted through vacuum liquid chromatography on silica gel followed by gel permeation chromatography on Sephadex LH-20, with characterization via NMR spectroscopy.

Historical & Cultural Context

Tinospora cordifolia, the source of tinosporide, has been used in Ayurveda for centuries as 'Guduchi' for immunomodulation, diabetes, inflammation, and fever. While the plant has extensive traditional use spanning Indian medicine systems, tinosporide itself is not specifically mentioned in historical contexts.

Health Benefits

• May support cognitive function through acetylcholinesterase inhibition (IC₅₀ 13.45 μg/ml in vitro studies only)
• Potential memory enhancement via cholinergic pathway modulation (preliminary in vitro evidence)
• May offer neuroprotective benefits based on molecular docking studies (in silico evidence only)
• Possible anti-inflammatory effects (inferred from parent plant studies, not tinosporide-specific)
• Traditional use for immune support (based on Tinospora cordifolia use, no direct tinosporide evidence)

How It Works

Tinosporide inhibits acetylcholinesterase (AChE) with an IC₅₀ of approximately 13.45 μg/ml in vitro, reducing the hydrolysis of acetylcholine and thereby prolonging cholinergic neurotransmission at muscarinic and nicotinic receptors. Molecular docking studies suggest tinosporide binds within the active gorge of AChE, interacting with catalytic residues Ser203 and His447 in a manner analogous to established cholinesterase inhibitors. Secondary mechanisms under investigation include modulation of oxidative stress pathways and possible interaction with NMDA receptor signaling, though these remain purely in silico or early in vitro findings.

Scientific Research

No human clinical trials, RCTs, or meta-analyses specifically on tinosporide have been conducted. The only related clinical evidence comes from a pilot trial (PMID: 33520840) using Tinospora cordifolia extract (not isolated tinosporide) in hypertriglyceridemia patients, showing suppression of inflammatory markers. All tinosporide-specific evidence is limited to in vitro acetylcholinesterase inhibition studies and in silico ADMET predictions.

Clinical Summary

To date, no published human clinical trials have evaluated tinosporide as an isolated compound. Available evidence is restricted to in vitro enzyme inhibition assays and computational molecular docking simulations, which, while hypothesis-generating, cannot establish efficacy or safe dosing in humans. Some animal studies on whole Tinospora cordifolia extracts report cognitive improvements, but attributing these effects specifically to tinosporide versus other constituents such as berberine, palmatine, or tinocordiside is not currently possible. The overall evidence base is at an early preclinical stage, and any therapeutic claims require validation through randomized controlled trials.

Nutritional Profile

Tinosporide is a clerodane-type furanoid diterpene compound isolated from Tinospora cordifolia (Guduchi/Giloy). It is a pure bioactive compound, not a whole food ingredient, and therefore lacks conventional macronutrient or micronutrient content.

**Chemical Identity:**
- Class: Clerodane furanoid diterpene lactone
- Molecular Formula: C₂₀H₂₄O₆
- Molecular Weight: ~364.4 g/mol
- CAS-like identity: Trace constituent of Tinospora cordifolia stem

**Concentration in Source Plant:**
- Found in very low concentrations in Tinospora cordifolia stems (typically <0.1% of dry extract weight)
- Isolated alongside related compounds: tinosporon, columbin, and isocolumbin

**Bioactive Compound Profile:**
- Primary bioactive: Furanoid diterpene lactone skeleton with clerodane framework
- Contains α,β-unsaturated lactone moiety (potentially responsible for bioactivity)
- Hydroxyl and acetoxy functional groups contribute to reactivity

**Bioavailability Notes:**
- No clinical pharmacokinetic data available for isolated tinosporide
- Lipophilic diterpene nature suggests potential for passive membrane diffusion
- Oral bioavailability presumed low due to first-pass metabolism (extrapolated from similar diterpenes)
- Blood-brain barrier penetration suggested by in silico molecular docking studies only
- No established dietary reference intake, therapeutic dose, or GRAS status as isolated compound

Preparation & Dosage

No clinically studied dosage ranges for tinosporide in any form are available due to absence of human trials. In vitro studies used concentrations yielding IC₅₀ of 13.45 μg/ml for acetylcholinesterase inhibition, but no human dosing has been established. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Bacopa monnieri, Ginkgo biloba, Lion's Mane, Phosphatidylserine, Huperzine A

Safety & Interactions

No clinical safety profile exists for isolated tinosporide, as human trials have not been conducted. Extrapolating from whole Tinospora cordifolia research, potential concerns include mild gastrointestinal upset and, at high doses, possible immunostimulatory effects that could be contraindicated in autoimmune conditions or organ transplant recipients. Because tinosporide mechanistically inhibits acetylcholinesterase, additive cholinergic effects are theoretically possible when combined with pharmaceutical AChE inhibitors such as donepezil or rivastigmine, potentially increasing the risk of bradycardia, nausea, or excessive secretions. Pregnant and breastfeeding individuals should avoid isolated tinosporide due to a complete absence of reproductive safety data.